Catalent, Inc. revenue for the last year amounted to 4.28 B USD, the most of which — 2.29 B USD — came from its highest performing source at the moment, Pharma and Consumer Health. The greatest contribution to the revenue figure was made by United States — last year it brought Catalent, Inc. 2.77 B USD, and the year before that — 3.11 B USD.